Parker Hannifin
PH
$0.00
-0.10%
Parker-Hannifin Corporation is a global leader in motion and control technologies, designing and manufacturing critical components for aerospace, industrial, and mobile equipment markets. The company operates as a diversified industrial conglomerate, with a distinct competitive identity built on a vast portfolio of engineered components that enable cross-selling and system-level solutions for complex machinery. The current investor narrative is heavily focused on strategic growth through acquisitions, as evidenced by the recent deal to acquire CIRCOR's aerospace business, which is seen as a catalyst for immediate margin and earnings expansion, alongside ongoing debates about the sustainability of its robust profitability in a potentially moderating industrial cycle.…
PH
Parker Hannifin
$0.00
Related headlines
Investment Opinion: Should I buy PH Today?
Rating & Thesis: Hold. Parker-Hannifin is a high-quality industrial with outstanding fundamentals, but its premium valuation fully reflects this quality, offering limited near-term margin of safety for new capital. The overwhelmingly bullish analyst sentiment (5 Buys/Overweight vs. 1 Hold) supports a positive long-term view, but the current price near 52-week highs demands patience.
Supporting Evidence: The Hold rating is supported by four key data points. First, the forward P/E of 28.4x is elevated and suggests high growth expectations. Second, while profitability is superb (25.8% ROE, 17.7% net margin), revenue growth has decelerated to 9.1% YoY. Third, the strong free cash flow yield of ~3.7% provides a floor via shareholder returns. Fourth, the stock trades at 94% of its 52-week high, indicating limited immediate upside before facing technical resistance at $1,034.96.
Risks & Conditions: The two biggest risks are a sharper-than-expected industrial slowdown hurting revenues and a valuation deration if earnings growth fails to meet lofty expectations. This Hold would upgrade to a Buy if the forward P/E compressed meaningfully below 25x (offering a better entry point) or if the CIRCOR acquisition demonstrates clear, above-plan margin accretion in upcoming quarters. It would downgrade to Sell if quarterly revenue growth decelerates further below 5% or if operating margins show sustained contraction. Relative to its own history and the expectation of continued excellence, the stock is fairly valued to slightly overvalued.
Sign up to view all
PH 12-Month Price Forecast
The 12-month outlook for PH is one of high-quality execution within a fully valued framework. The base case (60% probability) is for range-bound performance as the company delivers on its solid fundamentals but struggles to drive multiple expansion from current elevated levels. The bull case relies on flawless execution of the growth-by-acquisition strategy and a benign macro backdrop. The bear case, while lower probability, highlights the stock's vulnerability to an earnings disappointment given its premium rating. The stance is neutral; the stock is a 'hold' for existing investors but lacks a compelling risk/reward setup for new money. An upgrade to bullish would require evidence that the 28.4x forward P/E is justified by a re-acceleration of organic growth to the mid-teens.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Parker Hannifin's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
6 analysts
Implied Upside
—
vs. current price
Analyst Count
6
covering this stock
Price Range
$0 - $0
Analyst target range
Analyst coverage for Parker-Hannifin is limited in the provided data, with only 6 analysts tracked, which is lower than typical for a large-cap industrial of its size; this may indicate the dataset is incomplete. Based on the available institutional ratings, sentiment is overwhelmingly bullish, with recent actions from firms like Barclays, Wells Fargo, JP Morgan, and Jefferies all maintaining "Overweight" or "Buy" equivalents, while only Stifel maintains a "Hold." The consensus leans strongly positive, though a precise average target price and implied upside cannot be calculated from the given data. The target price range and specific upgrade/downgrade patterns are not provided in the analyst data, but the recent news of a major acquisition is a clear catalyst that likely supports the bullish institutional thesis focused on margin accretion and strategic growth.
Bulls vs Bears: PH Investment Factors
The bull case for Parker-Hannifin is anchored in its exceptional profitability, strong cash generation, and a strategic acquisition-led growth model that commands a premium valuation. The bear case highlights the risks of paying a premium for decelerating growth in a cyclical stock with above-market volatility. Currently, the bull side holds stronger evidence due to the company's demonstrable operational excellence and strategic catalysts, but the margin of safety is thin. The single most important tension in the investment debate is whether the company's acquisition strategy and superior margins can sustainably justify its elevated forward P/E of 28.4x in the face of moderating organic revenue growth.
Bullish
- Exceptional Profitability & ROE: Parker-Hannifin's net margin of 17.7% and return on equity of 25.8% are exceptionally high for an industrial company, demonstrating superior operational efficiency and capital allocation. This profitability provides a significant buffer against cyclical downturns and funds strategic initiatives.
- Strong Free Cash Flow Generation: The company generates robust free cash flow, with TTM FCF of $3.34 billion, equating to a 3.7% FCF yield. This substantial cash generation underpins shareholder returns and provides ample firepower for accretive acquisitions, such as the recent CIRCOR aerospace deal, without straining the balance sheet.
- Strategic Growth via Acquisitions: The acquisition of CIRCOR's aerospace business is a targeted move to bolster the high-margin Aerospace Systems segment. This strategy of consolidating fragmented markets is expected to provide immediate margin and earnings accretion, supporting future growth beyond organic cycles.
- Resilient Technical Uptrend: Despite recent volatility, the stock remains in a primary uptrend, up 40.08% over the past year and trading at 94% of its 52-week high. The recent 13.10% one-month gain shows strong momentum recovering from a -19.52% drawdown, indicating underlying investor confidence.
Bearish
- Elevated Valuation Multiples: The stock trades at a forward P/E of 28.4x and a trailing P/E of 25.4x, which is at the higher end of its historical range (17x-33x). This premium valuation leaves little room for multiple expansion and increases sensitivity to any earnings disappointment or growth deceleration.
- Revenue Growth Deceleration: Recent quarterly revenue growth has moderated to 9.1% YoY, a significant deceleration from the high-teens growth seen in prior fiscal years. This normalization post-pandemic surge raises questions about the sustainability of top-line momentum in a potentially moderating industrial cycle.
- High Beta & Cyclical Volatility: With a beta of 1.14, PH is 14% more volatile than the broader market, reflecting its sensitivity to industrial and macroeconomic cycles. The recent -19.52% maximum drawdown exemplifies this inherent volatility, posing a risk management challenge for investors.
- Limited Analyst Coverage & Data: The provided dataset shows only 6 analyst ratings, which is unusually low for a large-cap industrial. This limited coverage could obscure a full consensus view and precise target price, potentially increasing information asymmetry and stock price volatility.
PH Technical Analysis
The stock is in a sustained uptrend over the past year, evidenced by a 40.08% price increase, but has recently experienced significant volatility and a pullback from its highs. Currently trading at $968.92, the price sits at approximately 94% of its 52-week high of $1,034.96 and well above its 52-week low of $691.47, indicating the stock is near the upper end of its annual range, which reflects strong momentum but also potential overextension and vulnerability to a correction. Recent momentum shows a sharp divergence, with a strong 13.10% gain over the past month contrasting with a more modest 9.06% gain over three months, suggesting a recent recovery rally after a period of weakness; this is further highlighted by a maximum drawdown of -19.52% during the provided period, indicating the stock has weathered a significant pullback. Key technical levels are clearly defined by the 52-week high at $1,034.96 as major resistance and the 52-week low at $691.47 as major support; a decisive breakout above resistance would signal a resumption of the primary bull trend, while a breakdown below recent lows near $823 could indicate a deeper correction. With a beta of 1.14, the stock exhibits 14% more volatility than the broader market, which is a relevant consideration for risk management given its industrial cyclicality.
Beta
1.11
1.11x market volatility
Max Drawdown
-19.5%
Largest decline past year
52-Week Range
$692-$1035
Price range past year
Annual Return
+35.3%
Cumulative gain past year
| Period | PH Return | S&P 500 |
|---|---|---|
| 1m | +15.1% | -1.3% |
| 3m | +6.0% | +13.6% |
| 6m | +7.7% | +9.0% |
| 1y | +35.3% | +19.1% |
| ytd | +7.7% | +9.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PH Fundamental Analysis
Revenue growth remains positive but shows signs of moderation, with the most recent quarterly revenue of $5.17 billion representing a 9.1% year-over-year increase; however, this growth rate has decelerated from the high-teens percentages seen in prior fiscal years, indicating a normalization post-pandemic surge. Segment data reveals the Diversified Industrial segment ($3.47 billion) is the larger revenue driver, while the Aerospace Systems segment ($1.71 billion) is a key high-margin growth engine, particularly bolstered by recent acquisitions. Profitability is exceptionally strong, with the company reporting net income of $845 million and a net margin of 17.7% for the latest quarter; gross margin stands at a healthy 37.32%, and operating margin is 21.14%, reflecting efficient cost management and a favorable product mix, with margins remaining stable to slightly improved over recent quarters. The balance sheet and cash flow position are robust, with a debt-to-equity ratio of 0.70 indicating moderate leverage, a strong return on equity of 25.8%, and substantial free cash flow generation of $3.34 billion on a trailing twelve-month basis; this strong FCF, which equates to a yield of approximately 3.7% based on market cap, provides ample capacity for dividends, share buybacks, and strategic acquisitions like the recent CIRCOR deal without straining financial health.
Quarterly Revenue
$5.2B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.37%
Latest Quarter
Free Cash Flow
$3.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PH Overvalued?
Given the company's consistent profitability with net income of $845 million, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 25.4x and a forward PE of 28.4x; the higher forward multiple suggests the market is pricing in expectations for future earnings growth, potentially from acquisitions and margin initiatives. Compared to sector averages (data not available in the provided set for a direct industry comparison), the trailing PE of 25.4x appears elevated for a traditional industrial, likely commanding a premium justified by Parker's superior margins, strong ROE of 25.8%, and its strategic positioning as a consolidator in fragmented markets. Historically, the current trailing PE of 25.4x is above the stock's own recent historical range, which has fluctuated between approximately 17x and 33x over the past few years; trading near the higher end of this band suggests the market has largely priced in the company's operational excellence and growth initiatives, leaving less room for multiple expansion and increasing sensitivity to any earnings disappointment.
PE
25.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~61x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Parker-Hannifin's primary financial risk is not leverage, as its debt-to-equity ratio of 0.70 is moderate, but rather its dependence on continued high profitability to justify its premium valuation. The net margin of 17.7%, while strong, must be sustained; any significant compression could trigger a sharp multiple derating. Furthermore, the company's growth narrative is increasingly reliant on acquisitions like CIRCOR, introducing integration and execution risks. A failure to achieve projected synergies or margin accretion from these deals would undermine a key pillar of the investment thesis.
Market & Competitive Risks: The stock's elevated forward P/E of 28.4x, trading near the top of its historical range, presents a clear valuation compression risk. If interest rates remain elevated or the industrial cycle weakens, growth-oriented industrials like PH could see multiples contract toward their historical mean. Its beta of 1.14 confirms higher sensitivity to broader market and economic downturns. Competitively, while Parker's diversified portfolio is a strength, it faces constant pressure from both larger conglomerates and niche players, particularly in its high-margin aerospace segment where the CIRCOR acquisition aims to bolster its position.
Worst-Case Scenario: The most damaging scenario involves a simultaneous industrial recession and an acquisition integration failure. This could lead to a double hit of organic revenue decline and missed synergy targets, causing earnings to fall short of the high expectations embedded in the 28.4x forward P/E. In this adverse environment, the stock could experience a severe derating, potentially revisiting its 52-week low of $691.47. From the current price of ~$969, this represents a realistic downside of approximately -29%. A more probable bear-case pullback could target the recent significant support level near $823, implying a -15% decline.
FAQ
The key risks are, in order of severity: 1) Valuation Risk: The high forward P/E of 28.4x could compress if growth slows, posing a -15% to -29% downside to recent support or the 52-week low. 2) Cyclical/Macro Risk: With a beta of 1.14, the stock is sensitive to industrial downturns which could hurt the 9.1% revenue growth. 3) Execution Risk: The growth narrative depends on successful integration of acquisitions like CIRCOR; missteps could hurt margins and investor confidence. 4) Competitive Risk: Intense competition in both industrial and aerospace markets could pressure pricing and market share.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $950 and $1,035 as it executes solidly but struggles with multiple expansion. The Bull Case (25% probability) targets $1,035 to $1,100+ on successful acquisition integration and resilient growth. The Bear Case (15% probability) warns of a drop to the $823-$900 range on an industrial slowdown and earnings miss. The base case is most likely, anchored by the assumption that PH will meet, but not significantly exceed, the high expectations embedded in its current valuation.
PH stock is fairly valued to slightly overvalued based on current metrics. Its forward P/E of 28.4x is at the higher end of its own historical range (approx. 17x-33x), suggesting the market is paying a premium for its exceptional profitability (25.8% ROE) and strategic growth initiatives. This valuation implies the market expects the company to successfully execute its acquisition strategy and maintain high earnings growth. Compared to many traditional industrials, it commands a premium, which is justified by its superior margins but also increases its sensitivity to earnings disappointments.
PH is a good stock for investors who already own it or for those seeking a long-term holding in a high-quality industrial. However, for new capital at the current price near $969, the risk/reward is balanced, warranting a Hold rating. The stock trades at a full forward P/E of 28.4x, leaving limited margin for error, and recent revenue growth has decelerated to 9.1%. It becomes a more compelling buy on a pullback toward the $900-$950 range, which would offer a better entry point into its strong fundamentals and acquisition story.
PH is primarily suitable for a long-term investment horizon of 3-5 years. Its value proposition is built on consistent execution, strategic acquisitions, and compounding cash returns—themes that play out over multiple business cycles. The stock's beta of 1.14 and recent -19.52% drawdown make it volatile for short-term trading. Furthermore, its modest dividend yield of ~1% is not a primary income driver. Investors should be prepared to hold through cyclical volatility to benefit from the company's quality and growth strategy.